Dc..This is why we believe Radient is going to reverse merge with Provista Diagnostics..It is not boiler type ..They just didn't interpret the article correctly..Let me explain it to them. The newsletter was stating how PLS/William had all those in the pipeline..We know Provista DX kept the Breast, Ovarian, and Lung Cancer tests..That is backed up from William in an article interview not a make believe email you understand..
Launched in 2004 as Provista Life Sciences, the company initially positioned itself as a mezzanine developer of molecular diagnostics that aimed to acquire early stage biomarker tests, advance them to the clinical stage, and then sell them.
In this manner it developed a diagnostics pipeline covering a number of disease areas including Alzheimer's, Parkinson's, ovarian cancer, and lung cancer. It also developed its original breast cancer test, called the BT Test, that it sold in Ireland and the UK through International Health Technology.
